Radius Health (RDUS) Tops Q4 EPS by 19c, Revenues Beat

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.23), $0.19 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $62.78 million versus the consensus estimate of $59.44 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Faraday Future unveils nine robot models, prices start at $9,990
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Lumentum shares rise on analyst upgrades, AI demand outlook